Skip to main content
. 2022 Apr 12;5(4):e226920. doi: 10.1001/jamanetworkopen.2022.6920

Figure 1. Flow Diagram of the Selection Criteria and Patient Populations Used in the Analysis of Subcutaneous Treatment With Casirivimab and Imdevimab and Nontreated Control Participants.

Figure 1.

ED indicates emergency department; mAb, monoclonal antibody.